Shares of NetEase, Inc. (NASDAQ:NTES) fell during Friday’s session after the company reported worse-than-expected first-quarter revenue. NetEase reported…
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that topline clinical